期刊
JOURNAL OF TRANSLATIONAL MEDICINE
卷 17, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s12967-019-1991-3
关键词
mRNA; Influenza; Universal vaccine; Intranodal; Nucleoprotein; T cell
资金
- Seventh Framework Programme of the EU (FP7-HEALTH-2013-INNOVATION-1) [602570-2]
- Wetenschappelijk Fonds Willy Gepts
- Instituut voor Innovatie door Wetenschap en Technologie (IWT)
- Ghent University Special Research Fund [BOF12/GOA/014]
- FWO-Vlaanderen [G043515N]
- FP7 Marie Curie Initial Training Network VACTRAIN
BackgroundCurrent human influenza vaccines lack the adaptability to match the mutational rate of the virus and therefore require annual revisions. Because of extensive manufacturing times and the possibility that antigenic alterations occur during viral vaccine strain production, an inherent risk exists for antigenic mismatch between the new influenza vaccine and circulating viruses. Targeting more conserved antigens such as nucleoprotein (NP) could provide a more sustainable vaccination strategy by inducing long term and heterosubtypic protection against influenza. We previously demonstrated that intranodal mRNA injection can induce potent antigen-specific T-cell responses. In this study, we investigated whether intranodal administration of mRNA encoding NP can induce T-cell responses capable of protecting against a heterologous influenza virus challenge.MethodsBALB/c mice were immunized in the inguinal lymph nodes with different vaccination regimens of mRNA encoding NP. Immune responses were compared with NP DNA vaccination via IFN-gamma ELISPOT and in vivo cytotoxicity. For survival experiments, mice were prime-boost vaccinated with 17 mu g NP mRNA and infected with 1LD50 of H1N1 influenza virus 8weeks after boost. Weight was monitored and viral titers, cytokines and immune cell populations in the bronchoalveolar lavage, and IFN-gamma responses in the spleen were analyzed.ResultsOur results demonstrate that NP mRNA induces superior systemic T-cell responses against NP compared to classical DNA vaccination. These responses were sustained for several weeks even at low vaccine doses. Upon challenge infection, vaccination with NP mRNA resulted in reduced lung viral titers and improved recovery from infection. Finally, we show that vaccination with NP mRNA affects the immune response in infected lungs by lowering immune cell infiltration while increasing the fraction of T cells, monocytes and MHC II+ alveolar macrophages within immune infiltrates. This change was associated with altered levels of both pro- and anti-inflammatory cytokines.ConclusionsThese findings suggest that intranodal vaccination with NP mRNA induces cross-strain immunity against influenza, but also highlight a paradox of influenza immunity, whereby robust immune responses can provide protection, but can also transiently exacerbate symptoms during infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据